ISRCTN91685765进行中（未招募）未知
Driving improvements for prostate biopsy patients using Paige Prostate AI software to determine the benefits of pathologist-led diagnosis before and after the deployment of AI assistance (ARTICULATE PRO)
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 1,500
研究概览
简要总结
2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35626380/ (added 01/07/2022)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Male
入选标准
- •All patients undergoing prostate biopsy for suspected prostate cancer
排除标准
- •1. Patients who have opted out of clinical care via the existing 'consent to examination or treatment policy'
- •2. Non-prostate biopsy tissue
研究者
相似试验
进行中（未招募）
2 期
Dose escalation to intraprostatic tumour nodules in localised prostate cancerCancerISRCTN04483921Institute for Cancer Research (UK)265
已完成
不适用
Identification of gene markers associated with prognosis for patients with prostate cancerPrognostic markers of prostate cancerCancerISRCTN11560295Sichuan University3,000
已完成
不适用
PROACTIVE: prostate cancer support intervention for active surveillanceMen with localised prostate cancer being managed with active surveillanceCancerISRCTN38893965niversity of Southampton60
已完成
不适用
PREDICT: Prostate Patient StudyProstate cancerCancerISRCTN28468474Cambridge University Hospitals NHS Foundation Trust156
已完成
不适用
Biopsy diagnosis of prostate cancer in patients with suspected prostate cancer undergoing their first biopsy: comparison of target biopsy alone vs target biopsy in addition to standard biopsyProstate cancerCancerISRCTN60263108Ospedale San Luigi Gonzaga384